Auxano Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85M | Buy |
41,262
+1,870
| +5% | +$129K | 0.67% | 23 |
|
|
2025
Q1 | $2.74M | Buy |
39,392
+8,949
| +29% | +$621K | 0.72% | 24 |
|
|
2024
Q4 | $2.62M | Buy |
30,443
+429
| +1% | +$36.9K | 0.66% | 23 |
|
|
2024
Q3 | $3.57M | Sell |
30,014
-13
| -0% | -$1.55K | 0.93% | 19 |
|
|
2024
Q2 | $4.29M | Sell |
30,027
-208
| -0.7% | -$29.7K | 1.19% | 18 |
|
|
2024
Q1 | $3.88M | Buy |
30,235
+587
| +2% | +$75.4K | 1.13% | 18 |
|
|
2023
Q4 | $3.07M | Sell |
29,648
-180
| -0.6% | -$18.6K | 1.03% | 20 |
|
|
2023
Q3 | $2.71M | Sell |
29,828
-23,442
| -44% | -$2.13M | 1.11% | 19 |
|
|
2023
Q2 | $4.24M | Hold |
53,270
| – | – | 1.7% | 14 |
|
|
2023
Q1 | $4.24M | Sell |
53,270
-2,322
| -4% | -$185K | 1.7% | 14 |
|
|
2022
Q4 | $3.76M | Buy |
55,592
+154
| +0.3% | +$10.4K | 1.7% | 14 |
|
|
2022
Q3 | $2.76M | Buy |
55,438
+3,970
| +8% | +$198K | 1.27% | 17 |
|
|
2022
Q2 | $2.87M | Buy |
51,468
+1,386
| +3% | +$77.2K | 1.42% | 17 |
|
|
2022
Q1 | $2.78M | Buy |
50,082
+272
| +0.5% | +$15.1K | 1.18% | 18 |
|
|
2021
Q4 | $2.79M | Buy |
49,810
+116
| +0.2% | +$6.5K | 1.25% | 19 |
|
|
2021
Q3 | $2.39M | Sell |
49,694
-904
| -2% | -$43.4K | 1.07% | 19 |
|
|
2021
Q2 | $2.12M | Buy |
50,598
+528
| +1% | +$22.1K | 0.97% | 20 |
|
|
2021
Q1 | $1.69M | Buy |
50,070
+1,428
| +3% | +$48.1K | 1.04% | 23 |
|
|
2020
Q4 | $1.7M | Buy |
48,642
+2,304
| +5% | +$80.5K | 1.12% | 19 |
|
|
2020
Q3 | $1.61M | Buy |
46,338
+2,466
| +6% | +$85.6K | 1.24% | 19 |
|
|
2020
Q2 | $1.44M | Buy |
43,872
+350
| +0.8% | +$11.5K | 1.19% | 21 |
|
|
2020
Q1 | $1.31M | Buy |
+43,522
| New | +$1.31M | 1.19% | 21 |
|